Proteomes are an entire set of proteins which is expressed in genomes, and proteomics refers to the large-scale study of these proteomes, that include study of the functions and structure of proteins that can be used in diagnosis and treatment of various diseases, and in the process of drug discovery. Proteomics is used to analyze the interaction of proteins with each other, action of proteins in metabolic pathways, rate of the production of proteins, and the modification process of the proteins.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/proteomics-market

Global Proteomics market is expected to grow significantly during the forecast period. Some of the major factors driving growth of the global proteomics market are rising demand for personalized medicine, increasing research and development investments, technological advancements, and availability of government and private funding. Personalized medicine is manufactured according to the treatment condition and helps in the better treatment and quick recovery of the patients. The benefits of the personalized medicine for the treatment of different types of cancer is further driving the growth of the global proteomics market.

Download Free Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/proteomics-market/report-sample

Some of the key players in the global proteomics market are Agilent Technologies Inc., Bruker Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Waters Corporation, Danaher Corporation, Luminex Corporation, and PerkinElmer Inc.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=proteomics-market

With respect to strategic developments, various new product launches and strategic alliances have been taking place in the patient positioning equipment market.

In June 2017, Waters Corporation introduced the latest version of Progenesis QI for proteomics software. This software will enable the researchers to generate more results in comparatively less time.

In June 2017, Thermo Fisher Scientific Inc launched a new high-performing Orbitrap mass spectrometer. It is designed to produce superior quality results in the proteomics researches.
Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com